Zobrazeno 1 - 10
of 135
pro vyhledávání: '"KANAME NOSAKI"'
Autor:
Kaho Miura, Yoshiyuki Sano, Seiji Niho, Kenji Kawasumi, Nobuo Mochizuki, Kiyotaka Yoh, Shingo Matsumoto, Yoshitaka Zenke, Takaya Ikeda, Kaname Nosaki, Keisuke Kirita, Hibiki Udagawa, Koichi Goto, Toshikatsu Kawasaki, Kazuhiko Hanada
Publikováno v:
Thoracic Cancer, Vol 12, Iss 13, Pp 1983-1994 (2021)
Abstract Background It has recently been suggested that concomitant medication may affect the clinical outcome of patients treated with immune checkpoint inhibitors (ICIs). However, only a few studies on the impact of concomitant medication on immune
Externí odkaz:
https://doaj.org/article/c2b2b23ff3964b8ba27171c6dc3821fb
Autor:
Naoko Sueoka‐Aragane, Chiho Nakashima, Hironori Yoshida, Naohisa Matsumoto, Kentaro Iwanaga, Noriyuki Ebi, Akihiro Nishiyama, Kazuhiro Yatera, Shoichi Kuyama, Minoru Fukuda, Sunao Ushijima, Hitomi Umeguchi, Daijiro Harada, Kosuke Kashiwabara, Takayuki Suetsugu, Nobukazu Fujimoto, Fumihiro Tanaka, Hidetaka Uramoto, Chiharu Yoshii, Katsumi Nakatomi, Genju Koh, Nobuhiko Seki, Keisuke Aoe, Kaname Nosaki, Koji Inoue, Ayako Takamori, Atsushi Kawaguchi
Publikováno v:
Cancer Medicine, Vol 10, Iss 12, Pp 3873-3885 (2021)
Abstract Background EGFR mutations are good predictive markers of efficacy of EGFR tyrosine kinase inhibitors (EGFR‐TKI), but whether comprehensive genomic analysis beyond EGFR itself with circulating tumor DNA (ctDNA) adds further predictive or pr
Externí odkaz:
https://doaj.org/article/9fdb0934bf3d40bbb7a19d2b98a77955
Autor:
Mototsugu Shimokawa, Kaname Nosaki, Takashi Seto, Kadoaki Ohashi, Masahiro Morise, Hidehito Horinouchi, Jun Sakakibara, Haruyasu Murakami, Seiji Yano, Miyako Satouchi, Shingo Matsumoto, Koichi Goto, Kiyotaka Yoh
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-6 (2020)
Abstract Background MET-deregulated non-small cell lung cancer represents an urgent clinical need because of the lack of specific therapies. Although recent studies have suggested a potential role for crizotinib in patients harboring MET gene alterat
Externí odkaz:
https://doaj.org/article/0abc824990b2414ea3f8da3c729b62d3
Autor:
Mototsugu Shimokawa, Hiroshi Tanaka, Nobuyuki Yamamoto, Koichi Azuma, Hidetoshi Hayashi, Ryo Toyozawa, Kazumi Nishino, Kazuhiko Nakagawa, Isamu Okamoto, Hideo Saka, Takashi Seto, Kaname Nosaki, Shunichi Sugawara, Haruyasu Murakami, Terufumi Kato, Seiji Niho, Masahide Oki, Hiroshige Yoshioka, Haruko Daga, Rie Tohnai
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 2 (2022)
Background PD-L1 expression on tumor cells is a marker of PD-1/PD-L1 antibody treatment efficacy for advanced non-small cell lung cancer (NSCLC). PD-L1 antibody (atezolizumab) prolongs overall survival (OS) compared with platinum doublet as first-lin
Externí odkaz:
https://doaj.org/article/937f7175a0d347ba8b5600013b992f6c
Autor:
Naoki Haratake, Takashi Seto, Shinkichi Takamori, Ryo Toyozawa, Kaname Nosaki, Naoko Miura, Taro Ohba, Gouji Toyokawa, Kenichi Taguchi, Masafumi Yamaguchi, Mototsugu Shimokawa, Mitsuhiro Takenoyama
Publikováno v:
Thoracic Cancer, Vol 10, Iss 9, Pp 1779-1787 (2019)
Background Most non‐small cell lung cancer (NSCLC) patients relapse on anaplastic lymphoma kinase‐tyrosine kinase inhibitor (ALK‐TKI) therapy because of acquired resistance. Rebiopsy is recommended to provide optimal therapy after relapse for s
Externí odkaz:
https://doaj.org/article/ace1fff5d8aa4be1bb629186648528c3
Autor:
Kiichiro Ninomiya, MD, PhD, Shunsuke Teraoka, MD, Yoshitaka Zenke, MD, PhD, Hirotsugu Kenmotsu, MD, PhD, Yukiko Nakamura, MD, Yusuke Okuma, MD, PhD, Akihiro Tamiya, MD, Kaname Nosaki, MD, Masahiro Morise, MD, PhD, Keiju Aokage, MD, Yuko Oya, MD, Toshiyuki Kozuki, MD, PhD, Tomohiro Sakamoto, MD, PhD, Kentaro Tanaka, MD, PhD, Hisashi Tanaka, MD, PhD, Junko Tanizaki, MD, PhD, Satoru Miura, MD, PhD, Hideaki Mizutani, MD, Eisaku Miyauchi, MD, PhD, Ou Yamaguchi, MD, PhD, Noriyuki Ebi, MD, Yasushi Goto, MD, PhD, Takaaki Sasaki, MD, PhD, Haruko Daga, MD, PhD, Satoshi Morita, PhD, Takeharu Yamanaka, PhD, Shinsuke Amano, BCom, Kazuo Hasegawa, BFA, Chiyo K. Imamura, PhD, Kenichi Suzuki, PhD, Kazuko Nakajima, PhD, Hitomi Nishimoto, MN, Satoshi Oizumi, MD, PhD, Toyoaki Hida, MD, PhD, Katsuyuki Hotta, MD, PHD, MPH, Yuichi Takiguchi, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 1, Pp 100107- (2021)
Patients with NSCLC in East Asia, including Japan, frequently contain EGFR mutations. In 2018, we published the latest full clinical practice guidelines on the basis of those provided by the Japanese Lung Cancer Society Guidelines Committee. The purp
Externí odkaz:
https://doaj.org/article/5ceda8a606294ebc9bef7784fdc89eeb
Autor:
Kaname Nosaki, Katsuyuki Hamada, Yuto Takashima, Miyako Sagara, Yumiko Matsumura, Shohei Miyamoto, Yasuki Hijikata, Toshihiko Okazaki, Yoichi Nakanishi, Kenzaburo Tani
Publikováno v:
Molecular Therapy: Oncolytics, Vol 3, Iss C (2016)
Although various therapies are available to treat cancers, including surgery, chemotherapy, and radiotherapy, cancer has been the leading cause of death in Japan for the last 30 years, and new therapeutic modalities are urgently needed. As a new moda
Externí odkaz:
https://doaj.org/article/0c5ac81fd52648a3843b7466fa6b709c
Autor:
Masafumi Yamaguchi, Fumihiko Hirai, Kenichi Taguchi, Ryo Toyozawa, Makoto Edagawa, Shinichiro Shimamatsu, Kaname Nosaki, Takashi Seto, Mitsuhiro Takenoyama, Yukito Ichinose
Publikováno v:
Surgical Case Reports, Vol 3, Iss 1, Pp 1-2 (2017)
Abstract Pure ground-glass opacity nodules (p-GGN) on high-resolution computed tomography (HRCT) generally have been considering typically associated with adenocarcinoma with less invasive nature. We herein reported a patient presenting focal p-GGN o
Externí odkaz:
https://doaj.org/article/24224da709da423d8b16b4f74998ed7e
Autor:
Yutaro, Tamiya, Tokiko, Nakai, Ayako, Suzuki, Sachiyo, Mimaki, Katsuya, Tsuchihara, Kei, Sato, Kiyotaka, Yoh, Shingo, Matsumoto, Yoshitaka, Zenke, Kaname, Nosaki, Hiroki, Izumi, Yuji, Shibata, Tetsuya, Sakai, Tetsuro, Taki, Saori, Miyazaki, Reiko, Watanabe, Naoya, Sakamoto, Shingo, Sakashita, Motohiro, Kojima, Naozumi, Hashimoto, Masahiro, Tsuboi, Koichi, Goto, Genichiro, Ishii
Publikováno v:
Lung Cancer. 174:125-132
Tertiary lymphoid structures (TLS) are observed in several cancers and are associated with favorable prognosis. This study aimed to examine the clinicopathological, genetic, and gene expression profiles of lung adenocarcinoma patients with TLS.A tota
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1687e21ca3745bd5ac82c06cb6b3a994
https://doi.org/10.1016/j.lungcan.2022.11.001
https://doi.org/10.1016/j.lungcan.2022.11.001
Autor:
Akira Sugimoto, Shingo Matsumoto, Hibiki Udagawa, Ryo Itotani, Yuko Usui, Shigeki Umemura, Kazumi Nishino, Ichiro Nakachi, Shoichi Kuyama, Haruko Daga, Satoshi Hara, Shingo Miyamoto, Terufumi Kato, Jun Sakakibara-Konishi, Eriko Tabata, Taku Nakagawa, Tomoya Kawaguchi, Tetsuya Sakai, Yuji Shibata, Hiroki Izumi, Kaname Nosaki, Yoshitaka Zenke, Kiyotaka Yoh, Koichi Goto
Publikováno v:
Clinical Cancer Research. 29:1506-1514
Purpose: We evaluated plasma cell-free DNA (cfDNA) and tissue-based sequencing concordance for comprehensive oncogenic driver detection in non–small cell lung cancer (NSCLC) using a large-scale prospective screening cohort (LC-SCRUM-Liquid). Experi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6cc897d5d43308fd6f8fe4d851c8d24
https://doi.org/10.1158/1078-0432.ccr-22-1749
https://doi.org/10.1158/1078-0432.ccr-22-1749